Clinical Comparison: Mechanisms, Dosing & Practical Differences
What Is Best Wegovy or Mounjaro: Understanding the Core Differences
When determining what is best between Wegovy or Mounjaro for your weight management journey, the fundamental difference lies in their mechanisms of action. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural fullness hormone to reduce appetite and promote satiety after smaller meals. Mounjaro contains tirzepatide, a dual GIP and GLP-1 receptor agonist that targets two hormone pathways simultaneously, potentially affecting both glucose regulation and appetite control. Both are prescription-only medicines that require clinical assessment and must be used alongside a reduced-calorie diet and increased physical activity.
The choice between these treatments isn't about which is universally "better" - it's about which mechanism and dosing schedule aligns with your individual circumstances and medical history. EverydayMeds provides both options through our GPhC-registered pharmacy (#9012878), allowing you and your prescriber to make an evidence-based decision. Our online assessment process evaluates your suitability for either treatment, ensuring you receive the most appropriate option based on clinical guidelines rather than marketing claims.
Wegovy vs Mounjaro Pricing: Transparent Costs for UK Patients
Understanding the cost implications when deciding what is best between Wegovy or Mounjaro requires examining both individual pen prices and long-term treatment expenses. Wegovy pricing at EverydayMeds starts from £79.99 for the 0.25mg starter dose (weeks 1-4), progressing to £94.99 for 0.5mg, £99.99 for 1mg, £139.99 for 1.7mg, and £209.99 for the 2.4mg maintenance dose. New customers apply code FIRST40 at checkout to reach these final prices, whilst returning customers use DOSE25. Our bundle options like the Intro Duo (0.25mg & 0.5mg) at £169.99 provide convenient multi-month supply without multiple orders.
Mounjaro follows a different pricing structure due to its distinct formulation and dosing schedule, though both treatments represent significant investments in your health journey. The key consideration isn't just the upfront cost per pen, but the total monthly expense at maintenance doses and the practical value of features like storage flexibility. Both treatments are available with the same clinical assessment process, prescriber review within 3 working days (or 24 hours express), and next-day cold-chain delivery once approved.
Clinical Evidence: What Is Best Wegovy or Mounjaro Based on Trial Data
The clinical evidence for both treatments comes from robust phase 3 trials, though direct head-to-head comparisons aren't available due to different trial designs and patient populations. Wegovy's efficacy was demonstrated in the STEP trial programme, where patients taking semaglutide alongside diet and exercise achieved an average of approximately clinically studied weight loss at 68 weeks in STEP 1 (Wilding et al., NEJM, 2021). The STEP 5 trial showed sustained weight loss of around 15.2% at 2 years, whilst the recent SELECT cardiovascular outcomes trial demonstrated a 20% reduction in major cardiovascular events.
Mounjaro's evidence comes from the SURMOUNT trials, showing its dual hormone approach may offer different benefits in certain patient populations. However, comparing percentage weight loss between trials can be misleading due to varying baseline characteristics, study durations, and endpoint definitions. Your prescriber can evaluate which evidence base is most relevant to your specific medical history and weight management goals during the clinical assessment process.
How Wegovy Works: GLP-1 Mechanism for Weight Management
Wegovy's active ingredient semaglutide functions as a GLP-1 receptor agonist, essentially mimicking a hormone your intestines naturally produce when you eat. This mechanism works on multiple levels: it slows gastric emptying so food stays in your stomach longer, promoting feelings of fullness after smaller portions. The medication also acts on appetite centres in your brain, potentially reducing food cravings and the psychological drive to eat beyond your body's needs. Additionally, it may influence reward pathways associated with food, though individual responses vary significantly. The once-weekly injection schedule provides consistent hormone levels throughout the week, unlike daily medications that create peaks and troughs. This sustained action supports consistent appetite regulation, making it easier to maintain the reduced-calorie diet that's essential for weight loss success.
Streamlined Online Ordering: What Is Best Wegovy or Mounjaro Assessment Process
Determining what is best between Wegovy or Mounjaro starts with our comprehensive 3-minute online clinical assessment, designed to evaluate your suitability for either treatment option. The assessment covers your medical history, current medications, previous weight loss attempts, and specific health markers that influence prescribing decisions for these prescription-only medicines. Our qualified prescribers review your submission within 3 working days (or 24 hours with express service), considering both treatments' suitability based on NICE guidelines and MHRA licensing criteria. Once approved, your chosen treatment ships via next-day delivery in temperature-controlled packaging to maintain medication stability. This process ensures you receive clinically appropriate treatment whilst maintaining the convenience of online access to these specialist weight management medications.
Storage and Practical Considerations: Wegovy vs Mounjaro Daily Life Impact
The practical differences between these treatments can significantly influence what is best for your lifestyle and circumstances. Wegovy offers superior storage flexibility, maintaining stability for up to 6 weeks at room temperature below 30°C once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. This makes Wegovy more suitable for frequent travellers, those with unreliable refrigeration, or anyone who values storage convenience. Both use pre-filled injection pens, but Wegovy's FlexTouch design from Novo Nordisk has been refined through years of diabetes treatment use. The dose escalation schedules also differ: Wegovy follows a structured 16-week progression to the 2.4mg maintenance dose, whilst Mounjaro has its own titration protocol. Your tolerance of injection frequency, storage requirements, and dose adjustment preferences all factor into determining the most suitable option.
UK-Specific Considerations: What Is Best Wegovy or Mounjaro for British Patients
For UK patients determining what is best between Wegovy or Mounjaro, several Britain-specific factors merit consideration beyond clinical efficacy. NICE guidance TA875 specifically recommends Wegovy for weight management with specialist support, providing a clear regulatory pathway that many UK prescribers find reassuring. The medication's longer market presence in the UK means more accumulated real-world safety data and prescriber familiarity, particularly important for patients with complex medical histories. EverydayMeds' GPhC registration (#9012878) ensures both treatments meet UK pharmaceutical standards, with cold-chain delivery nationwide including Scottish Highlands and Northern Ireland.
Additionally, the NHS weight management pathway increasingly recognises GLP-1 treatments, meaning private treatment through EverydayMeds might eventually coordinate with NHS specialist services. Our UK-based clinical team understands the specific challenges British patients face, from NHS waiting times to private healthcare navigation, ensuring your treatment choice aligns with broader UK healthcare realities rather than just clinical trial data.
Making Your Decision: Expert Guidance for Wegovy vs Mounjaro Choice
The question of what is best between Wegovy or Mounjaro ultimately requires personalised clinical assessment rather than a one-size-fits-all answer. Both treatments are available through EverydayMeds from £79.99, with new customers using code FIRST40 and returning customers applying DOSE25 at checkout for these final prices. Our online assessment process evaluates your individual circumstances, medical history, and treatment goals to guide appropriate prescribing decisions. The clinical evidence supports both options for suitable patients, but factors like storage requirements, dosing schedules, and your specific health profile will influence which represents the optimal choice. Remember that successful weight management with either treatment requires commitment to the essential lifestyle components: reduced-calorie diet and increased physical activity alongside your chosen medication. Start your clinical assessment today at https://everydaymeds.co.uk/collections/wegovy to determine which option aligns best with your weight management journey.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
